CDC Harm Reduction toolkit graphic 580x325 033121 768x430

COVID-19 Pandemic Impact on Harm Reduction Services: An Environmental Scan

Apr 29, 2021 | Julia Zigman, Guest Author

The COVID-19 pandemic has significantly impacted the overdose crisis in the U.S. and magnified disparities in access to health care, social services and other basic needs experienced by people who use drugs and people with substance use disorders. Overdose death rates are estimated to be 22.8% higher in July 2020 compared to July 2019. For decades, harm reduction organizations have provided essential, nonjudgmental services that promote safer drug use, prevent overdose death, link people to treatment and recovery supports, and support holistic health. During the pandemic, harm reduction organizations have faced substantial disruptions, and in some cases have had to suspend or terminate services. Despite these challenges, harm reduction providers have implemented a range of adaptations and innovations to continue supporting their participants while adhering to COVID-19 safety guidance for staff and participants.

To better understand the impact of the COVID-19 pandemic on harm reduction organizations and people who use drugs, the National Council for Behavioral Health, with support from the Centers for Disease Control and Prevention (CDC), conducted an environmental scan consisting of a literature review and 21 key informant interviews with staff from harm reduction organizations in the U.S.

Information collected through the literature and from key informants demonstrate that the pandemic has resulted in:

  • Increased health and social harms to people who use drugs.
  • Significant disruptions to harm reduction services and operations.
  • Innovative adaptations by harm reduction organizations to continue to serve the needs of participants.

Findings from the environmental scan are detailed in COVID-19 Pandemic Impact on Harm Reduction Services: An Environmental Scan.

For more information please contact Shannon Mace at ShannonM@TheNationalCouncil.org.


NACCHO logo small version02 square N pms321 Invert

About Julia Zigman

Pronouns: she/her

Julia Zigman is a Program Analyst on the NACCHO HIV, STI, & Viral Hepatitis team. Julia focuses primarily on NACCHO’s Ending the HIV Epidemic portfolio and is a lead staff member for the HIV, STI, and Viral Hepatitis Workgroup. Learn more about these programs here.

More posts by Julia Zigman

NACCHO logo small version02 square N pms321

About Guest Author

NACCHO periodically invites guest authors to write first-person accounts of their work in public health. To submit your own story for consideration, please visit our form.

More posts by Guest Author

Related Posts

National council behavioral health 2
  • COVID-19
  • HIV, STI, & Viral Hepatitis
  • Opioid Overdose Epidemic

Funding Opportunity: Innovative Harm Reduction...

The National Council for Behavioral Health (National Council), with support...

Oct 07, 2020 | Julia Zigman

Funding Opportunity: Innovative Harm Reduction...

KFF logo
  • HIV, STI, & Viral Hepatitis

Delivering HIV Care and Prevention in the COVID Era: A...

To better understand the pandemic’s impact on HIV, KFF surveyed the nation’s...

Jan 06, 2021 | Shalesha Majors

Delivering HIV Care and Prevention in the COVID Era: A...

Hepatitis
  • COVID-19
  • HIV, STI, & Viral Hepatitis

The State of Viral Hepatitis During the COVID-19 Pandemic

This resource highlights the impact of the COVID-19 pandemic on hepatitis...

Feb 16, 2021 | Kat Kelley

The State of Viral Hepatitis During the COVID-19 Pandemic

Syringe pile
  • HIV, STI, & Viral Hepatitis
  • Opioid Overdose Epidemic

White House Centers Harm Reduction and Equity in Year 1...

On April 1, the White House Office of National Drug Control Policy (ONDCP)...

Apr 07, 2021 | Kat Kelley

White House Centers Harm Reduction and Equity in Year 1...

Back to Top